Salinomycin Sodium Premix 10% 12% 45%

Manus Aktteva Biopharma LLP, a global supplier of Salinomycin Sodium Premix 10% 12% 45%, 53003-10-4 offers for your requirements of RND / Development quantities or commercials, based on status of the product. We can also offer its intermediates with supportive technical package required for evaluation.

Salinomycin Sodium Premix 10% 12% 45%, 53003-10-4, GMP, USFDA

CAS number:

53003-10-4

Chemical Name:

(2R)-2-((5S)-6-{5-[(10S,12R)-2-((6S,5R)-5-Ethyl-5-hydroxy-6-methylperhydro-2H-pyran-2-yl)-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxadispiro[4.1.5.3]pentadec-13-en-9-yl](1S,2S,3S,5R)-2-hydroxy-1,3-dimethyl-4-oxoheptyl}-5-methylperhydro-2H-pyran-2-yl)butanoi, Salinomycin Sodium Premix 10% 12% 45%

Pharmacopeia:

USP, EP, In House

Certificate:

GMP, USFDA

Application:

For R&D Purpose

Why Us
Your product search made swift, simplified & successful in experienced hands. Test us to get the best of us Active Pharmaceutical Ingredients & Intermediates. New Molecule R&D, Scale up & Commercialization Technical Data package, CMC data package & Drug master files for most of the products as a part of our service Our partnerships are market-driven and are aimed at delivering real business value to our clients To Strive harder & excel further for the sevice of mankind by offering our services to the industry

Global Sourcing

Goto Top